Periampullary Cancer ESPAC-3(v2) trial: a Randomised Controlled Phase III Trial of Adjuvant Chemotherapy Versus Observation in Patients With Periampullary Adenocarcinomas of the Head of the Pancreas

被引：0
|
作者：
Neoptolemos, J. [1 ]
Moore, M.
Cox, T. [1 ]
Valle, J. [2 ]
Palmer, D. [1 ]
Mcdonald, A. [3 ]
Carter, R. [4 ]
Tebbutt, N. [5 ]
Dervenis, C. [6 ]
Smith, D. [1 ]
Glimelius, B. [7 ]
Coxon, F. [8 ]
Lacaine, F. [9 ]
Middleton, M. [10 ]
Ghaneh, P. [1 ]
Bassi, C. [11 ]
Halloran, C. [1 ]
Olah, A. [12 ]
Rawcliffe, C. [1 ]
Buechler, M. [13 ]
机构：
[1] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
[2] Christie, Manchester, Lancs, England
[3] Univ Birmingham, Birmingham B15 2TT, W Midlands, England
[4] Glasgow Royal Infirm, Glasgow, Lanark, Scotland
[5] Austin Hosp, Heidelberg, Vic 3084, Australia
[6] Aiga Olga, Athens, Greece
[7] Univ Uppsala Hosp, Uppsala, Sweden
[8] No Canc Ctr, Newcastle Upon Tyne, Tyne & Wear, England
[9] Hosp Tenon, Paris, France
[10] John Radcliffe Hosp, Oxford OX3 9DU, England
[11] Univ Verona, I-37100 Verona, Italy
[12] Petz Aladar Hosp, Gyor, Hungary
[13] Univ Heidelberg, D-6900 Heidelberg, Germany
来源：
PANCREAS | 2011年 / 40卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1343 / 1343
页数：1
相关论文
共 50 条
  • [21] ESPAC-4: A Multicenter, International, Randomized Controlled Phase III Trial of Adjuvant Combination Chemotherapy of Gemcitabine (GEM) and Capecitabine (CAP), Versus Monotherapy Gemcitabine in Patients With Resected Pancreatic Ductal Adenocarcinoma
    Neoptolemos, J. P.
    Palmer, D.
    Ghaneh, P.
    Valle, J.
    Cunningham, D.
    Wadsley, J.
    Meyer, T.
    Anthoney, A.
    Glimelius, B.
    Falk, S.
    Lind, P.
    Izbicki, J.
    Middleton, G.
    Ross, P.
    Wasan, H.
    McDonald, A.
    Crosby, T.
    Psarelli, E.
    Hammel, P.
    Buechler, M. W.
    PANCREAS, 2016, 45 (10) : 1529 - 1529
  • [22] Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: Safety data from the multicentre phase 3 randomised ELDA trial
    Nuzzo, Francesco
    Morabito, Alessandro
    De Maio, Ermelinda
    Di Rella, Francesca
    Gravina, Adriano
    Labonia, Vincenzo
    Landi, Gabriella
    Pacilio, Carmen
    Piccirillo, Maria Carmela
    Rossi, Emanuela
    D'Aiuto, Giuseppe
    Thomas, Renato
    Gori, Stefania
    Colozza, Mariantonietta
    De Placido, Sabino
    Lauria, Rossella
    Signoriello, Giuseppe
    Gallo, Ciro
    Perrone, Francesco
    de Matteis, Andrea
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 66 (02) : 171 - 180
  • [23] Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial
    Chen, Lei
    Hu, Chao-Su
    Chen, Xiao-Zhong
    Hu, Guo-Qing
    Cheng, Zhi-Bin
    Sun, Yan
    Li, Wei-Xiong
    Chen, Yuan-Yuan
    Xie, Fang-Yun
    Liang, Shao-Bo
    Chen, Yong
    Xu, Ting-Ting
    Li, Bin
    Long, Guo-Xian
    Wang, Si-Yang
    Zheng, Bao-Min
    Guo, Ying
    Sun, Ying
    Mao, Yan-Ping
    Tang, Ling-Long
    Chen, Yu-Ming
    Liu, Meng-Zhong
    Ma, Jun
    LANCET ONCOLOGY, 2012, 13 (02): : 163 - 171
  • [24] CONKO-001: FINAL RESULTS OF THE RANDOMIZED, PROSPECTIVE, MULTICENTER PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY WITH GEMCITABINE VERSUS OBSERVATION IN PATIENTS WITH RESECTED PANCREATIC CANCER (PC)
    Riess, H.
    Neuhaus, P.
    Post, S.
    Gellert, K.
    Ridwelski, K.
    Schramm, H.
    Zuelke, C.
    Fahlke, J.
    Langrehr, J.
    Oettle, H.
    ANNALS OF ONCOLOGY, 2008, 19 : 45 - 46
  • [25] CONKO-001: Final results of the randomized, prospective, multicenter phase III trial of adjuvant chemotherapy with gemcitabine versus observation in patients with resected pancreatic cancer (PC)
    Neuhaus, P.
    Riess, H.
    Post, S.
    Gellert, K.
    Ridwelski, K.
    Schramm, H.
    Zuelke, C.
    Fahlke, J.
    Langrehr, J.
    Oettle, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [26] Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trial
    Chen, Lei
    Hu, Chao-Su
    Chen, Xiao-Zhong
    Hu, Guo-Qing
    Cheng, Zhi-Bin
    Sun, Yan
    Li, Wei-Xiong
    Chen, Yuan-Yuan
    Xie, Fang-Yun
    Liang, Shao-Bo
    Chen, Yong
    Xu, Ting-Ting
    Li, Bin
    Long, Guo-Xian
    Wang, Si-Yang
    Zheng, Bao-Min
    Guo, Ying
    Sun, Ying
    Mao, Yan-Ping
    Tang, Ling-Long
    Chen, Yu-Ming
    Liu, Meng-Zhong
    Ma, Jun
    EUROPEAN JOURNAL OF CANCER, 2017, 75 : 150 - 158
  • [27] Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
    Neoptolemos, John P.
    Palmer, Daniel H.
    Ghaneh, Paula
    Psarelli, Eftychia E.
    Valle, Juan W.
    Halloran, Christopher M.
    Faluyi, Olusola
    O'Reilly, Derek A.
    Cunningham, David
    Wadsley, Jonathan
    Darby, Suzanne
    Meyer, Tim
    Gillmore, Roopinder
    Anthoney, Alan
    Lind, Pehr
    Glimelius, Bengt
    Falk, Stephen
    Izbicki, Jakob R.
    Middleton, Gary William
    Cummins, Sebastian
    Ross, Paul J.
    Wasan, Harpreet
    McDonald, Alec
    Crosby, Tom
    Ma, Yuk Ting
    Patel, Kinnari
    Sherriff, David
    Soomal, Rubin
    Borg, David
    Sothi, Sharmila
    Hammel, Pascal
    Hackert, Thilo
    Jackson, Richard
    Buechler, Markus W.
    LANCET, 2017, 389 (10073): : 1011 - 1024
  • [28] Adjuvant therapy with pegylated interferon α-2b versus observation in resected stage III melanoma:: final results of EORTC 18991, a randomised phase 3 trial
    Eggermont, A. M. M.
    Suciu, S.
    Santinami, M.
    Testori, A.
    Kruit, W.
    Marsden, J.
    Punt, C. J. A.
    Sales, F.
    Gore, M.
    Mckie, R.
    Kusic, V.
    Dummer, R.
    Musat, E.
    Spatz, A.
    Keilholz, U.
    PIGMENT CELL & MELANOMA RESEARCH, 2008, 21 (02) : 290 - 290
  • [29] CapeOX perioperative chemotherapy versus postoperative chemotherapy for locally advanced resectable colon cancer: protocol for a two-period randomised controlled phase III trial
    Liu, Fangqi
    Tong, Tong
    Huang, Dan
    Yuan, Weitang
    Li, Dechuan
    Lin, Jianjiang
    Cai, Sanjun
    Xu, Ye
    Chen, Wenbin
    Sun, Yueming
    Zhuang, Jing
    BMJ OPEN, 2019, 9 (01):
  • [30] JASPAC 01: Randomized phase III trial of adjuvant chemotherapy with gemcitabine versus S-1 for patients with resected pancreatic cancer
    Fukutomi, Akira
    Uesaka, Katsuhiko
    Boku, Narikazu
    Kanemoto, Hideyuki
    Konishi, Masaru
    Matsumoto, Ippei
    Kaneoka, Yuji
    Shimizu, Yasuhiro
    Nakamori, Shoji
    Sakamoto, Hirohiko
    Morinaga, Soichiro
    Kainuma, Osamu
    Imai, Koji
    Sata, Naohiro
    Hishinuma, Shoichi
    Nakamura, Takayuki
    Kanai, Michio
    Hirano, Satoshi
    Yoshikawa, Yukinobu
    Ohashi, Yasuo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345